VAM
RPRX

Visium Asset Management’s Repros Therapeutics Inc. RPRX Stock Holding History

Visium Asset Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-391,700
Closed -$3.88M – 1366
2014
Q3 		$3.88M Sell
391,700
-1,449,099
-79% -$21.5M 0.06% 328
2014
Q2 		$31.8M Hold
1,840,799
– – 0.49% 34
2014
Q1 		$32.7M Buy
1,840,799
+100
+0% +$1.94K 0.53% 35
2013
Q4 		$33.7M Buy
1,840,699
+15,699
+0.9% +$296K 0.66% 24
2013
Q3 		$48.9M Hold
1,825,000
– – 1.11% 16
2013
Q2 		$33.7M Buy
+1,825,000
New +$32.2M 0.79% 30

Other funds holding RPRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
CC
CQS Cayman Camana Bay, Grand Cayman, Cayman Islands $2.26B AUM 1.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GAI
General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Visium Asset Management's RPRX Position: Q4 2014 in Review

Visium Asset Management sold out of Repros Therapeutics Inc. (RPRX) in Q4 2014, closing a stake of 391,700 shares — an estimated $3.88M sold.

Visium Asset Management first reported a position in RPRX in Q2 2013 and held it in 6 quarters. The position peaked at $48.9M in Q3 2013. 80 funds tracked by Wall St. Rank hold RPRX as of Q4 2014.

  • Visium Asset Management reported no remaining Repros Therapeutics Inc. position as of Q4 2014 after selling out during the quarter.
  • Visium Asset Management sold 391,700 Repros Therapeutics Inc. shares in Q4 2014, an estimated $3.88M.
  • Visium Asset Management first reported a position in Repros Therapeutics Inc. in Q2 2013 and held it in 6 quarters.
  • Visium Asset Management's Repros Therapeutics Inc. position peaked at $48.9M in Q3 2013.
  • 80 funds tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q4 2014.

Based on Visium Asset Management's 13F filing for Q4 2014, filed 13 Feb 2015.